Sweden: EIB launches first pre-IPO support to help European growth company access public markets

The European Investment Bank (EIB) has signed its first pre-IPO advisory agreement to help a European growth company prepare for access to public capital markets. The support is provided through the InvestEU Advisory Hub and aims to strengthen the ability of innovative European companies to grow and remain in Europe as they scale.

The agreement supports Swedish biotechnology company Anocca, based in Södertälje, which develops next-generation T-cell immunotherapies for cancer. T-cell immunotherapy is a form of treatment that uses a patient’s own immune cells, engineered to recognise and attack cancer cells more effectively.

Read full announcement (external link)

Originally published on 18 Mar

Read More

NIB co-finances biogas production in Eskilstuna, Sweden

NIB and Eskilstuna Biogas AB have signed a seven-year loan to co-finance the construction of a new biogas production plant in a facility near Eskilstuna, Sweden. The EUR 15 million loan is supported by the European Union under the InvestEU programme and is eligible under NIB’s InvestEU Framework Operation Green Mobility and Transport.

Read full announcement (external link)

Originally published on 26 Mar

Read More